SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-126856
Filing Date
2023-04-28
Accepted
2023-04-28 16:02:01
Documents
5
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A d417734ddef14a.htm DEF 14A 459341
2 GRAPHIC g417734dsp069.jpg GRAPHIC 166487
3 GRAPHIC g417734dsp070.jpg GRAPHIC 109874
4 GRAPHIC g417734g02k07.jpg GRAPHIC 28574
5 GRAPHIC g417734g34p02.jpg GRAPHIC 60341
  Complete submission text file 0001193125-23-126856.txt   948648
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38978 | Film No.: 23865739
SIC: 2834 Pharmaceutical Preparations